Contec Medical Systems Stock EBITDA

300869 Stock   15.12  0.77  4.85%   
Contec Medical Systems fundamentals help investors to digest information that contributes to Contec Medical's financial success or failures. It also enables traders to predict the movement of Contec Stock. The fundamental analysis module provides a way to measure Contec Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Contec Medical stock.
Last ReportedProjected for Next Year
EBITDA136.7 M214.3 M
The current year's EBITDA is expected to grow to about 214.3 M.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Contec Medical Systems Company EBITDA Analysis

Contec Medical's EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.

EBITDA

 = 

Revenue

-

Basic Expenses

More About EBITDA | All Equity Analysis

Current Contec Medical EBITDA

    
  136.65 M  
Most of Contec Medical's fundamental indicators, such as EBITDA, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Contec Medical Systems is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Competition

Contec Ebitda

Ebitda

214.26 Million

At present, Contec Medical's EBITDA is projected to increase significantly based on the last few years of reporting.
According to the company disclosure, Contec Medical Systems reported earnings before interest,tax, depreciation and amortization of 136.65 M. This is 84.43% lower than that of the Health Care Equipment & Supplies sector and 78.73% lower than that of the Health Care industry. The ebitda for all China stocks is 96.49% higher than that of the company.

Contec EBITDA Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Contec Medical's direct or indirect competition against its EBITDA to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Contec Medical could also be used in its relative valuation, which is a method of valuing Contec Medical by comparing valuation metrics of similar companies.
Contec Medical is currently under evaluation in ebitda category among its peers.

Contec Fundamentals

About Contec Medical Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Contec Medical Systems's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Contec Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Contec Medical Systems based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Contec Stock

Contec Medical financial ratios help investors to determine whether Contec Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Contec with respect to the benefits of owning Contec Medical security.